It has been announced at the Fourth European Breast Cancer Conference that Faslodex, the first of a new kinder class of breast cancer drug, is to be launched in Britain this summer.
Jenni is joined by Tony Howell, Professor of Oncology at Christie Hospital University of Manchester to discuss the effect of this new treatment.
